ArticleActa neuropathologica communications2025
Early metabolic reprogramming and carbonic anhydrase IX-mediated extracellular acidification drive radiotherapy-induced glioblastoma cell dedifferentiation.
Article in Acta neuropathologica communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundGlioblastomas (GBM) are brain tumors with the worst prognosis despite treatment with surgery and radio/chemotherapy, emphasizing the need for new therapies and improved treatment efficacy. Previously, we showed that clinically relevant ionizing radiation (IR) doses enhance GBM cell dedifferentiation into a stem-like phenotype, increasing stemness markers, self-renewal, and tumorigenic abilities. This work focuses on identifying early mechanisms driving this plasticity, particularly metabolic adaptations, as tumor metabolism may support therapy resistance and recurrence.
methodsIn this study, primary cell lines were established from GBM biopsies of several patients and cultured either in restrictive medium to form neurospheres (NS) enriched in GBM stem-like cells (GSC) or in normal medium to obtain their differentiated progenies. These differentiated GBM cells were then subjected to a short-term dedifferentiation protocol after IR (24 to 72 h) to characterize their metabolic and phenotypic properties.
resultsWe found that early stem marker increases after IR exposure coincide with higher oxygen consumption rate (OCR), mitochondrial ATP production, and extracellular acidification rate (ECAR). However, lactate production remained unchanged, and glucose uptake showed only a transient, nonspecific increase. This shift to oxidative mitochondrial metabolism, coupled with extracellular acidosis, promotes a stem-like phenotype and is associated with Carbonic Anhydrase IX (CA9) overexpression, an extracellular membrane protein producing H + to buffer intracellular pH. CA9 downregulation via ShRNA reduces extracellular acidification and blocks early IR-induced dedifferentiation, such as neurosphere (NS) formation and stem marker overexpression. Similarly, increased OCR and ECAR, often linked to CA9 overexpression, are observed in patient-derived GSC compared to their differentiated progenies.
conclusionsThese findings highlight CA9 as a potential target to block IR-induced early dedifferentiation process as well as the specific metabolic state of GSC. Our study strengthens the therapeutic potential of CA9 inhibition to limit GBM-associated acidic extracellular environment and enhance radiotherapy efficiency by limiting tumor cell plasticity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.